Literature DB >> 19282429

Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.

Yasuaki Bungyoku1, Ikuo Shoji1, Tatsuhiko Makine1, Tetsuya Adachi1, Kazumi Hayashida1, Motoko Nagano-Fujii1, Yoshi-Hiro Ide1, Lin Deng1, Hak Hotta1.   

Abstract

Robust production of infectious hepatitis C virus (HCV) in cell culture was realized by using the JFH1 strain and the homologous chimeric J6/JFH1 strain in Huh-7.5 cells, a highly HCV-permissive subclone of Huh-7 cells. In this study, we aimed to establish a more efficient HCV-production system and to gain some insight into the adaptation mechanisms of efficient HCV production. By serial passaging of J6/JFH1-infected Huh-7.5 cells, we obtained culture-adapted J6/JFH1 variants, designated P-27, P-38 and P-47. Sequence analyses revealed that the adaptive mutant viruses P-27, P-38 and P-47 possessed eight mutations [four in E2, two in NS2, one in NS5A and one in NS5B), 10 mutations [two additional mutations in the 5'-untranslated region (5'-UTR) and core] and 11 mutations (three additional mutations in 5'-UTR, core and NS5B), respectively. We introduced amino acid substitutions into the wild-type J6/JFH1 clone, generated recombinant viruses with adaptive mutations and analysed their infectivity and ability to produce infectious viruses. The viruses with the adaptive mutations exhibited higher expression of HCV proteins than did the wild type in Huh-7.5 cells. Moreover, we provide evidence suggesting that the mutation N534H in the E2 glycoprotein of the mutant viruses conferred an advantage at the entry level. We thus demonstrate that an efficient HCV-production system could be obtained by introducing adaptive mutations into the J6/JFH1 genome. The J6/JFH1-derived mutant viruses presented here would be a good tool for producing HCV particles with enhanced infectivity and for studying the molecular mechanism of HCV entry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282429     DOI: 10.1099/vir.0.010983-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 2.  Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.

Authors:  Megha Haridas Upadya; Jude Juventus Aweya; Yee-Joo Tan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.

Authors:  Troels K H Scheel; Judith M Gottwein; Thomas H R Carlsen; Yi-Ping Li; Tanja B Jensen; Ulrich Spengler; Nina Weis; Jens Bukh
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

5.  Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.

Authors:  François Helle; Gabrielle Vieyres; Laure Elkrief; Costin-Ioan Popescu; Czeslaw Wychowski; Véronique Descamps; Sandrine Castelain; Philippe Roingeard; Gilles Duverlie; Jean Dubuisson
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

Authors:  Alexander W Tarr; Richard A Urbanowicz; Mohamed R Hamed; Anna Albecka; C Patrick McClure; Richard J P Brown; William L Irving; Jean Dubuisson; Jonathan K Ball
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

7.  Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.

Authors:  Lin Deng; Ikuo Shoji; Wataru Ogawa; Shusaku Kaneda; Tomoyoshi Soga; Da-peng Jiang; Yoshi-Hiro Ide; Hak Hotta
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

8.  Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α.

Authors:  Chieko Matsui; Ikuo Shoji; Shusaku Kaneda; Imelda Rosalyn Sianipar; Lin Deng; Hak Hotta
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

9.  Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.

Authors:  Chieko Matsui; Lin Deng; Nanae Minami; Takayuki Abe; Kazuhiko Koike; Ikuo Shoji
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

10.  Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.

Authors:  Simrat Dhillon; Jeroen Witteveldt; Derek Gatherer; Ania M Owsianka; Mirjam B Zeisel; Muhammad N Zahid; Malgorzata Rychłowska; Steven K H Foung; Thomas F Baumert; Allan G N Angus; Arvind H Patel
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.